Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Purchases $16,430.00 in Stock

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Catherine Cusack purchased 1,000 shares of the business’s stock in a transaction that occurred on Friday, February 21st. The shares were purchased at an average price of $16.43 per share, for a total transaction of $16,430.00. Following the completion of the acquisition, the director now owns 59,083 shares of the company’s stock, valued at $970,733.69. The trade was a 1.72 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Catherine Cusack also recently made the following trade(s):

• On Monday, February 24th, Catherine Cusack purchased 1,500 shares of Sabra Health Care REIT stock. The shares were purchased at an average price of $15.92 per share, for a total transaction of $23,880.00.

Sabra Health Care REIT Stock Up 0.4 %

SBRA opened at $16.45 on Friday. The company’s 50-day moving average price is $16.78 and its two-hundred day moving average price is $17.61. Sabra Health Care REIT, Inc. has a twelve month low of $13.31 and a twelve month high of $20.03. The company has a quick ratio of 4.16, a current ratio of 4.32 and a debt-to-equity ratio of 0.88. The stock has a market cap of $3.91 billion, a price-to-earnings ratio of 31.04, a PEG ratio of 1.97 and a beta of 1.25.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The company had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. As a group, equities analysts expect that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Health Care REIT Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Friday, February 14th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 7.29%. The ex-dividend date is Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 226.42%.

Institutional Trading of Sabra Health Care REIT

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. VSM Wealth Advisory LLC purchased a new position in Sabra Health Care REIT in the 4th quarter worth approximately $26,000. Quarry LP purchased a new stake in shares of Sabra Health Care REIT in the 3rd quarter valued at $30,000. Assetmark Inc. boosted its stake in shares of Sabra Health Care REIT by 168.4% in the 3rd quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust’s stock valued at $37,000 after purchasing an additional 1,231 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in shares of Sabra Health Care REIT in the 3rd quarter valued at $59,000. Finally, GF Fund Management CO. LTD. purchased a new stake in shares of Sabra Health Care REIT in the 4th quarter valued at $74,000. Institutional investors own 99.40% of the company’s stock.

Analysts Set New Price Targets

SBRA has been the topic of several analyst reports. Citizens Jmp upgraded shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. JMP Securities upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price on the stock in a research note on Tuesday, January 7th. Mizuho reiterated a “neutral” rating and issued a $20.00 target price on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Finally, Truist Financial cut shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and dropped their target price for the company from $18.00 to $17.00 in a research note on Friday, January 17th. Three equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $18.86.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.